Role of lymphocyte co-stimulation pathways and extracellular vesicles in cardiovascular damage of chronic uremic patients and new therapeutic strategies

Keyphrases

• Extracellular Vesicles 100%
• Lymphocytes 100%
• Costimulation 100%
• New Therapeutic Approaches 100%
• Uremic Patients 100%
• CD40L 100%
• Cardiovascular Damage 100%
• Chronic Kidney Disease 52%
• Poly(methyl methacrylate) 35%
• Indoxyl Sulfate 23%
• Vascular Smooth muscle Cells 23%
• Major Adverse Cardiovascular Events 23%
• Endothelial Cells 17%
• Osteoblastic Differentiation 17%
• Uremia 11%
• Cardiovascular Risk 11%
• Uremic Toxins 11%
• High Cardiovascular Risk 11%
• Polysulfone 11%
• Predictive Value 5%
• Adsorption 5%
• Hepcidin 5%
• ROS Production 5%
• Dialysis Patients 5%
• Dialysis Facility 5%
• Clinical High Risk 5%
• Biochemical Parameters 5%
• Cell-to-cell 5%
• Vascular Damage 5%
• Best Predictor 5%
• Blood Levels 5%
• Disease-related 5%
• Dialyzer 5%
• Sulfate Reduction 5%
• Inflammation Markers 5%
• Risk Level 5%
• Monocyte Adhesion 5%
• Mass Removal 5%
• Extracellular Vesicle Characterization 5%
• Chronic Kidney Disease Patient 5%
• Endothelial Cell Inflammation 5%

Medicine and Dentistry

• Chronic Kidney Disease 100%
• Co-Stimulation 100%
• Lymphocyte 100%
• Cardiovascular System 100%
• Poly(methyl Methacrylate) 60%
• Cardiovascular Risk 40%
• Endothelial Cell 40%
• Indican 40%
• Vascular Smooth Muscle Cell 40%
• In Vitro 20%
• Uremia 20%
• Mediator 20%
• Uremic Toxin 20%
• CD40 Ligand 20%
• Polysulfone 20%
• Inflammation 20%
• Hemodialysis 10%
• Hepcidin 10%
• Blood Vessel Injury 10%
• Monocyte 10%
• Reactive Oxygen Species 10%

Immunology and Microbiology

• Co-Stimulation 100%
• Lymphocyte 100%
• Cardiovascular System 100%
• Vascular Smooth Muscle Cell 40%
• Endothelial Cells 40%
• Mediator 20%
• CD40 Ligand 20%
• In Vitro 20%
• Inflammation 20%
• Monocyte 10%
• Blood Level 10%
• Hemodialysis 10%